Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:10 PM
Ignite Modification Date:
2025-12-24 @ 2:10 PM
NCT ID:
NCT02934295
Eligibility Criteria:
Inclusion Criteria:
* Women over 18
* Rubella serology negative, ambiguous or weakly positive during a first prenatal consultation and for which the second determination of the immunity anti rubella is necessary after 18 weeks of pregnancy
* Accepting the rubella vaccination after the childbirth;
* Accepting a blood test, during a postnatal consultation, 6 in 8 weeks after vaccination, to verify their immunity towards the virus of the rubella.
* Affiliated to a social security scheme
* Having given a written consent
Exclusion Criteria:
* Rubella contracted since the first serology realized during the first prenatal consultation
* Autoimmune pathologies
* Intolerance / allergy known about a previous vaccination whatever it is
* Immunosuppression (HIV, transplants)
* Injection of multivalent immunoglobulins (except anti-D)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02934295
Study Brief:
Protocol Section:
NCT02934295